Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Cancer Immunotherapy and Biomarkers

82 та иш

  1. Analysis of cancer incidence structure in the Republic of Uzbekistan

    Mirzagaleb Tillyashaykhov, Sayde Djanklich, S. N. Ibragimov +1

    МақолаEsophageal Cancer Research and TreatmentOncologia i radiologia Kazakhstana20214 иқтибос
    ABI

  2. Changes In Tumor Infiltrating Lymphocytes Of Peripheral Blood And Tissue During Chemotherapy In Patients With Gastric Cancer

    G. G. Khakimova, G.A. Khakimov Khakimov, Shakhnoz G. Khakimova +2

    МақолаGastric Cancer Management and OutcomesThe American Journal of Medical Sciences and Pharmaceutical Research20211 иқтибос
    ABI

  3. QANDLI DIABET KASALLIGINI DAVOLASHDA ISHLATILADIGAN O’SIMLIKLARNING KIMYOVIY TARKIBI

    Ibrohimjon Rahmonovich Asqarov, Dlafruz Valijon qizi G’aniyeva, Obidjon Shaxabidinovich Abdulloyev

    МақолаEducation, Innovation and Language StudiesJournal of Chemistry of Goods and Traditional Medicine20221 иқтибос
    ABI

  4. Artificial intelligence for chimeric antigen receptor-based therapies: a comprehensive review of current applications and future perspectives

    Muqadas Shahzadi, Hamad Rafique, Ahmad Waheed +4

    Шарҳ мақолаCAR-T cell therapy researchTherapeutic Advances in Vaccines and Immunotherapy20241 иқтибос
    ABI

  5. The evolution of cellular-based immunotherapy in the treatment of gastric cancer: an overview of clinical trials

    Lang Wu, Jasur Rizaev, Khaled Fahmi Fawy +7

    МақолаCAR-T cell therapy researchClinical & Translational Oncology20261 иқтибос
    ABI

  6. Investigation of erythrocytes tritium labelled glucose uptake in patients with diabetes mellutis

    Zulaykho Shamansurova, Turakulov IaKh, G.S. Akramova +5

    МақолаSkin Diseases and Diabetes20000 иқтибос
    ABI

  7. DIAGNOSTIC VALUE OF STUDYING THE LEVELS OF PRO- AND ANTI-INFLAMMATORY CYTOKINES OF THE IMMUNE SYSTEM IN PATIENTS WITH BREAST CANCER

    L. Alimkhodjaeva

    МақолаCancer Immunotherapy and BiomarkersDOAJ (DOAJ: Directory of Open Access Journals)20140 иқтибос
    ABI

  8. The specific features of cellular, humoral, and activation markers of the immune system and the biophysical parameters of superficial peripheral lymphocyte membranes in patients with breast cancer

    L. T. Alimkhodzhayeva, A. D. Zikiryakhodzhayev

    МақолаImmunotherapy and Immune ResponsesDOAJ (DOAJ: Directory of Open Access Journals)20140 иқтибос
    ABI

  9. 67P Diagnostic value of immune histochemical and molecular biological parameters in younger patients with breast cancer

    L. Alimkhodjaeva, D. Nishanov, L. Zakirova

    МақолаCancer Immunotherapy and BiomarkersAnnals of Oncology20150 иқтибос
    ABI

  10. Determination chromosome aberration as a factor of prognosis in treatment of bilateral renal cell carcinoma

    N. Rahimov, Boyko V. Elena, Valieva T. Rano +1

    МақолаMultiple and Secondary Primary CancersAnnals of Oncology20170 иқтибос
    ABI

  11. Importance of cytokines in women with ovarian cancer

    Bakhodir Kurbanov

    МақолаCancer Immunotherapy and BiomarkersAnnals of Oncology20170 иқтибос
    ABI

  12. Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases

    Veronika Blum, Beat Müller, Silvia Höfer +7

    МақолаCancer Immunotherapy and BiomarkersEuropean Journal of Dermatology20180 иқтибос
    ABI

  13. Clinicopathological significance of HER2 and EGFR expression in urothelial carcinoma: A single center study

    Gulrukh Botiralieva, Mirzagaleb Tillyashaykhov, A. Yusupbekov

    МақолаBladder and Urothelial Cancer TreatmentsAnnals of Oncology20180 иқтибос
    ABI

  14. MAIN MOLECULAR-BIOLOGICAL MARKERS IN СERVICAL CANCER

    Sergey Viktorovich Kamishov

    МақолаCancer-related molecular mechanisms researchJournal of science and education20180 иқтибос
    ABI

  15. PO-291 The disbalance of the basic cytokines of the immune system in patients with ovarian cancer on the background of immunotherapy

    S. Kamishov

    МақолаCancer Immunotherapy and BiomarkersESMO Open20180 иқтибос
    ABI

  16. Study of cellular immunity in children and adolescents with nasopharyngeal cancer

    Nargiza Karimova, D. Polatova, A Z Ismailova +2

    МақолаImmune Cell Function and InteractionAnnals of Oncology20180 иқтибос
    ABI

  17. MAIN MOLECULAR-BIOLOGICAL MARKERS IN СERVICAL CANCER

    Sergey Viktorovich Kamishov

    МақолаCancer-related molecular mechanisms researchJournal of science and education20180 иқтибос
    ABI

  18. Evaluation of the effect of cholesorption on the concentration of TNF-α in the serum of the blood in tumours of the biliopancreatoduodenal zone

    M. Salokhiddinov, S. Matmuratov, E. Stamou

    МақолаCholangiocarcinoma and Gallbladder Cancer StudiesAnnals of Oncology20190 иқтибос
    ABI

  19. Intratumoral Nanofluidic System for Enhancing Tumor Biodistribution of Agonist CD40 Antibody

    Corrine Ying Xuan Chua, Jeremy Ho, Antonia Susnjar +6

    МақолаNanopore and Nanochannel Transport StudiesAdvanced Therapeutics20200 иқтибос
    ABI

  20. Expression, Prognosis, and Immune Infiltrates Analyses of E2F-Related Transcription Factor Family in Human Brain and CNS Cancer

    Pan Liao, Shuzhen Han, Honglan Qu

    МақолаCancer Immunotherapy and BiomarkersSSRN Electronic Journal20200 иқтибос
    ABI

  21. DERN CONTROL POINT INHIBITORS AND THEIR POSSIBILITIES FOR THE THERAPY OF METASTATIC UROTELIAL CANCER

    M.N. Tillyashajhov, С В Камышов, E. P. Bojko

    МақолаBladder and Urothelial Cancer TreatmentsEurasianUnionofScientists20200 иқтибос
    ABI

  22. 18P Influence of local immunity on the prognosis of gastric cancer

    Г. Р. Хакимова

    МақолаCancer Immunotherapy and BiomarkersAnnals of Oncology20200 иқтибос
    ABI

  23. Flanvotumab

    National Cancer Institute

    БошқаCancer Immunotherapy and BiomarkersDefinitions20200 иқтибос
    ABI

  24. Narnatumab

    National Cancer Institute

    БошқаCancer Immunotherapy and BiomarkersDefinitions20200 иқтибос
    ABI

  25. A REVIEW OF MODERN IMMUNOTHERAPY IN GASTROINTESTINAL MALIGNANT TUMORS

    A. Yusupbekov, S.V. Kamishov, A.A. Adilkhodjaev +2

    Шарҳ мақолаCancer Immunotherapy and BiomarkersEurasianUnionofScientists20200 иқтибос
    ABI